Building Partnerships to Expand Access to Cell Therapies
Experts discuss how collaboration among key stakeholders and organizations is reducing logistical barriers to access and bringing life-changing CAR T-cell therapies closer to patients.
8 min read |Open Access |Feature
In this month's President's message, Jose Cancelas, MD, PhD, CABP, discusses how the expansion of cell therapies and advanced biotherapies are reshaping the blood and biotherapies field while creating new possibilities for patients worldwide.
2 min read |Open Access |President’s Message
In recognition of his pioneering research and commitment to mentoring future leaders in the blood and biotherapies community, Don Siegel, PhD, MD, has been named the 2026 Emily Cooley Memorial Award recipient.
8 min read |Open Access |Feature
University Hospital in New Jersey becomes the first organization to achieve AABB accreditation for Emergency Prehospital and Scheduled Out-of-Hospital Transfusions.
7 min read |Open Access |In the Field
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
